MMP2 and breast carcinoma: In contrast to the effects of BST‐2 on breast cancer cells, in HT1080 (human fibrosarcoma epithelial cell line) and MDCK (canine kidney cells) cells, overexpression of BST‐2 decreased cell growth and migration due to reduced matrix metalloproteinase 2 (MMP‐2) activity 130.